Skip to main content

Country Hub

  • Country portal

Secondary nav

  • Gavi's next strategic period
  • #ForOurFuture
  • Ethics Hotline
  • English
  • Français
Home

Main navigation

  • Our Alliance
    About
    • Gavi Leap
    • Mission & vision
    • Our impact
    • Leadership
    Strategy
    • Current (2021–2025)
    • Next (2026–2030)
    • Vaccine Investment Strategy 2024
    • Risk management
    • Learning System Strategy
    • Gender & immunisation
    • Climate, health & immunisation
    Operating model
    • Our partners
    • Business model
    • People & leadership
    • Data & transparency
    Governance
    • Gavi Board
    • Governance & legal structures
    • Board & Committee minutes
    • Corporate Policies
    • Audit & investigations
    Market Shaping
    • Vaccine Innovation Prioritisation Strategy (VIPS)
    • Vaccine demand forecasting
    • Roadmaps
    • Product information: vaccines & cold chain equipment
    Global health & development
    • Sustainable Development Goals
    • International Health Partnership for UHC 2030
    • Decade of Vaccines Collaboration
    • Millennium Development Goals
    Work with us
    • Vacancies
    • Internships
    • RFPs & consulting opportunities

    Contact us ISO certification Phishing & fraud

    • About
      • Gavi Leap
      • Mission & vision
      • Our impact
      • Leadership
    • Strategy
      • Current (2021–2025)
      • Next (2026–2030)
      • Vaccine Investment Strategy 2024
      • Risk management
      • Learning System Strategy
      • Gender & immunisation
      • Climate, health & immunisation
    • Operating model
      • Our partners
      • Business model
      • People & leadership
      • Data & transparency
    • Governance
      • Gavi Board
      • Governance & legal structures
      • Board & Committee minutes
      • Corporate Policies
      • Audit & investigations
    • Market Shaping
      • Vaccine Innovation Prioritisation Strategy (VIPS)
      • Vaccine demand forecasting
      • Roadmaps
      • Product information: vaccines & cold chain equipment
    • Global health & development
      • Sustainable Development Goals
      • International Health Partnership for UHC 2030
      • Decade of Vaccines Collaboration
      • Millennium Development Goals
    • Work with us
      • Vacancies
      • Internships
      • RFPs & consulting opportunities

    Contact us ISO certification Phishing & fraud

  • Programmes & Impact
    How our support works
    • Support guidelines
    • Independent Review Committee
    • Joint appraisals
    • Country portal
    Programmatic support
    • Vaccine support
    • Funding for civil society organisations (CSOs)
    • Health systems & immunisation strengthening
    • Partners' Engagement Framework (PEF)
    • Global health security
    Regional manufacturing strategy
    • Overview
    • African Vaccine Manufacturing Accelerator (AVMA)
    • Vaccine market dashboard
    Country Hub
    • All countries
    • Africa
    • Americas
    • Eastern Mediterranean
    • Europe
    • South-East Asia
    • Western Pacific
    Our impact
    • Progress reports
    • Facts & figures
    • Digital health information (DHI)
    • Measuring our performance
    • Evaluation studies
    Programmatic policies
    • Eligibility & co-financing policies
    • Fragility, emergencies & displaced populations policy
    • Gender policy
    • Health systems & immunisation strengthening policy
    • Prioritisation mechanism
    • Risk policy
    • Self-procurement policy
    • Transparency & accountability
    • Vaccine donation policy

    About Gavi Facts & figures Contact us

    • How our support works
      • Support guidelines
      • Independent Review Committee
      • Joint appraisals
      • Country portal
    • Programmatic support
      • Vaccine support
      • Funding for civil society organisations (CSOs)
      • Health systems & immunisation strengthening
      • Partners' Engagement Framework (PEF)
      • Global health security
    • Regional manufacturing strategy
      • Overview
      • African Vaccine Manufacturing Accelerator (AVMA)
      • Vaccine market dashboard
    • Country Hub
      • All countries
      • Africa
      • Americas
      • Eastern Mediterranean
      • Europe
      • South-East Asia
      • Western Pacific
    • Our impact
      • Progress reports
      • Facts & figures
      • Digital health information (DHI)
      • Measuring our performance
      • Evaluation studies
    • Programmatic policies
      • Eligibility & co-financing policies
      • Fragility, emergencies & displaced populations policy
      • Gender policy
      • Health systems & immunisation strengthening policy
      • Prioritisation mechanism
      • Risk policy
      • Self-procurement policy
      • Transparency & accountability
      • Vaccine donation policy

    About Gavi Facts & figures Contact us

  • Investing in Gavi
    Resource mobilisation
    • Global Summit: Health & Prosperity through Immunisation
    • Process
    Funding
    • Overview 2000–2037
    Our donors
    • Donor governments and the European Union
    • Foundations, corporations, institutions and organisations
    Partnering with business
    • Partnership types
    • Why partner with Gavi
    Innovative financing
    • International Finance Facility for Immunisation (IFFIm)
    • Pneumococcal Advance Market Commitment (AMC)
    • Gavi Matching Fund
    • Loan buydown
    INFUSE
    • INFUSE community
    • Call for innovations

    Strategic finance

    Innovative financing

    As part of our long-term funding and private sector engagement strategy, we use innovative finance mechanisms to incentivise investment in immunisation.

    Learn more

    Key publication

    IO


    Gavi's Investment Opportunity 
    2026–2030

    Download

    Global Summit, 25 June 2025

    • Resource mobilisation
      • Global Summit: Health & Prosperity through Immunisation
      • Process
    • Funding
      • Overview 2000–2037
    • Our donors
      • Donor governments and the European Union
      • Foundations, corporations, institutions and organisations
    • Partnering with business
      • Partnership types
      • Why partner with Gavi
    • Innovative financing
      • International Finance Facility for Immunisation (IFFIm)
      • Pneumococcal Advance Market Commitment (AMC)
      • Gavi Matching Fund
      • Loan buydown
    • INFUSE
      • INFUSE community
      • Call for innovations

    Global Summit, 25 June 2025

  • VaccinesWork
    Topics
    • Stories from the community
    • Emerging threats
    • News from the lab
    • Tales from the past
    • Vaccine profiles
    • Gavi matters
    VaccinesWork

     

    VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.

    About | Homepage

    Since July 2025, Mauritania has been using the hexavalent vaccine, which combines protection against six childhood diseases in a single injection. Credit: Yamina Bendaïda
    Mauritania now offers the six-in-one childhood vaccine. Here’s why that matters 28 Nov 2025
    A mother awaits for her child to receive the measles vaccine from a health worker during a routine vaccination session in Ethiopia. Credit: Gavi/2024/Mulugeta Ayene
    Winning against measles: five charts that tell a remarkable 24-year story 28 Nov 2025
    A COVID-19 patient in South Africa, 2020. Rodger Bosch/AFP via Getty Images
    Long COVID’s hidden toll: the South Africans still battling fatigue, anxiety and memory loss 28 Nov 2025

    Latest VaccinesWork About VaccinesWork Contact the Editor

    • Topics
      • Stories from the community
      • Emerging threats
      • News from the lab
      • Tales from the past
      • Vaccine profiles
      • Gavi matters

    Latest VaccinesWork About VaccinesWork Contact the Editor

  • News & resources
    Media room
    • News releases
    • Media contacts
    • Media resources
    Resources
    • Insight reports
    • Communication toolkits
    • Leadership biographies
    • Progress reports
    • Publications
    Document library
    • Board & Committee minutes
    • Evaluations
    • Independent Review Committee (IRC) reports
    • Financial reports

    Latest insights

    Credit: Gavi/2022/Asad Zaidi

    Gavi’s role at the crossroads of climate change and immunisation

    Learn more

    News releases

    Gavi news releases

    View all our news releases to read the latest announcements

    View news releases

    About Gavi Facts & figures Contact us

    • Media room
      • News releases
      • Media contacts
      • Media resources
    • Resources
      • Insight reports
      • Communication toolkits
      • Leadership biographies
      • Progress reports
      • Publications
    • Document library
      • Board & Committee minutes
      • Evaluations
      • Independent Review Committee (IRC) reports
      • Financial reports

    About Gavi Facts & figures Contact us

    • Country portal
    • Gavi's next strategic period
    • #ForOurFuture
    • Ethics Hotline
    • English
    • Français
 

  • English
  • Français
  • Home
  • country news
  • All Country News

The Gambia news

Gavi Features

14 October 2016

Africa takes second “step” toward strengthening supply chain management

Africa takes second “step” toward strengthening supply chain management
Read more

22 February 2016

Meningitis A nearly eliminated in Africa through vaccination

Meningitis A nearly eliminated in Africa through vaccination
Read more

25 April 2017

Central African Republic: mother spreads word about meningitis A vaccine

Central African Republic: mother spreads word about meningitis A vaccine
Read more

Press Releases

8 December 2005

Hib Initiative - a new force in the fight against Hib meningitis and pneumonia

Hib Initiative - a new force in the fight against Hib meningitis and pneumonia
Read more

8 December 2005

New weapons against ancient foes - new generation vaccines will battle diseases that kill Millions

New weapons against ancient foes - new generation vaccines will battle diseases that kill Millions
Read more

29 June 2005

Routine immunisation virtually eliminates major killer of young children in The Gambia

Routine immunisation virtually eliminates major killer of young children in The Gambia
Read more

25 March 2005

Vaccine prevents deadly pneumonia in African children

Vaccine prevents deadly pneumonia in African children
Read more

9 August 2006

Routine use of Hib vaccine could lead to virtual elimination of killer disease in Africa

Routine use of Hib vaccine could lead to virtual elimination of killer disease in Africa
Read more

3 April 2007

Increasing immunization rates and new vaccine offer hope for Ethiopian children

Increasing immunization rates and new vaccine offer hope for Ethiopian children
Read more

Roi

14 April 2010

Hib Initiative: a GAVI success story

Hib Initiative: a GAVI success story
Read more

Statements

9 November 2012

GAVI statement on latest interim trial data on malaria vaccine candidate

GAVI statement on latest interim trial data on malaria vaccine candidate
Read more

14 May 2013

Rotavirus leading cause of diarrhoea

Rotavirus leading cause of diarrhoea
Read more

8 October 2013

GAVI statement on latest trial data on malaria vaccine candidate RTS,S

GAVI statement on latest trial data on malaria vaccine candidate RTS,S
Read more

18 September 2014

Nepal becomes first country to introduce IPV with Gavi support

Nepal becomes first country to introduce IPV with Gavi support
Read more
Home

Footer

  • Our Alliance
  • Programmes & impact
  • Investing in Gavi
  • VaccinesWork
  • News & resources

Country Hub

  • Country portal

Donate

  • #ForOurFuture
  • Donate

Footer nav

  • Careers
  • Contact
  • Ethics hotline
  • IFFIm
  • Privacy notice
  • Terms of use
  • Phishing and fraud

© Gavi 2025

  • Gavi LinkedIn
  • Gavi Twitter
  • Gavi Instagram
  • Gavi Facebook
  • Gavi YouTube
  • Gavi TikTok
VSN logoCAF International logo

Our achievements are thanks to the support and expertise of our founding partners

  • English
  • Français